Fractyl Health’s new diabetes approach is beyond GLP-1s

The company’s gene therapy candidate aims to shift Type 2 diabetes treatment from lifelong management to a potential one-time intervention. What if managing Type 2 diabetes no longer meant building your life around medications, injections, escalating prescriptions and constant glucose monitoring? What if the future of metabolic medicine looked like restoration, instead of maintenance? These […] The post Fractyl Health’s new diabetes approach is beyond GLP-1s appeared first on Longevity.Technology.